Spiperone
SIGMA/S7395 - solid
Synonym: 8-
CAS Number: 749-02-0
Empirical Formula (Hill Notation): C23H26FN3O2
Molecular Weight: 395.47
EC Number: 212-024-0
MDL Number: MFCD00055099
Linear Formula: C23H26FN3O2
Product Type: Chemical
| color | light yellow |
| form | solid |
| InChI | 1S/C23H26FN3O2/c24-19-10- |
| InChI key | DKGZKTPJOSAWFA-UHFFFAOYSA |
| Quality Level | 200 ![]() |
| SMILES string | Fc1ccc(cc1)C(=O)CCCN2CCC3 |
| solubility | 0.1 M HCl: slightly soluble 0.3 mg/mL |
| 45% (w/v) aq 2-hydroxypropyl-β-cyclode |
|
| ethanol: 1.5 mg/mL | |
| H2O: slightly soluble 0.2 mg/mL |
| Application: | Spiperone has been used to block the actions of 5-hydroxytryptamine (5-HT) receptor. It also has been used to study its anti tumor effects in glioblastoma (GBM) cell lines. |
| Application: | Spiperone was used to study the role of dopamine receptors in facilitating the male sexual behavior in quails.6 |
| Biochem/physiol Actions: | Selective D2 dopamine receptor antagonist; α1B-adrenoceptor antagonist; mixed 5-HT2A/5-HT1 serotonin receptor antagonist; antipsychotic. |
| General description: | Spiperone is a butyrophenone antipsychotic agent. It induces calcium-dependent chloride secretion in the airway and functions as a potential therapeutic target for cystic fibrosis. |
| Packaging: | 250 mg in glass bottle |
| Preparation Note: | Solutions may be stored for 1-2 days at 4 °C. |
| Symbol | ![]() GHS07,GHS08 |
| Signal word | Warning |
| Hazard statements | H302 - H361 |
| Precautionary statements | P201 - P301 + P312 + P330 - P308 + P313 |
| Hazard Codes | Xn |
| Risk Statements | 63-22 |
| Safety Statements | 36/37 |
| RIDADR | NONH for all modes of transport |
| WGK Germany | WGK 3 |
| Flash Point(F) | Not applicable |
| Flash Point(C) | Not applicable |
| UNSPSC | 12352200 |



